.jpg?20250513')
The National Health Regulatory Authority (NHRA) has reaffirmed the safety of all eye drops available in Bahrain. It follows a warning issued by the US Centre for Disease Control (CDC) over an eye drop that has been linked to the outbreak of a drug-resistant bacteria, leading to adverse events in at least 55 patients in the US. The NHRA said the drops were not imported into Bahrain. It also asserted that all existing products in the country were free from any contamination.
The US Food and Drug Administration warned that Artificial Tears eye drop, manufactured by India’s Global Pharma Healthcare Private Limited, has a potential bacterial contamination and the company has violated good manufacturing practices. The company, based in India’s southern city of Chennai, on Wednesday said it had issued a voluntary recall at the consumer level of unexpired lots of the eye drop, distributed in the US by EzriCare and Delsam Pharma.
&uuid=(email))